Morgan Stanley analyst Patrick Wood maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of ...

Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Truist Financial analyst Richard Newitter maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $120.00. The company’s shares closed yesterday at ...

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that develops, manufactures, and markets a broad range of innovative products.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income ...

The Athletic's James Mirtle examined its effect on the Toronto Maple Leafs' efforts to re-sign ... Oilers And More Turning to the Boston Bruins, Bruins president Cam Neely last month said his ...

But that could be changing soon. Martha Sheridan, head of the Meet Boston tourism bureau, just returned from a trade mission to Hyderabad, organized by the Brand USA marketing partnership ...

After hours: 7:58:35 p.m. EST ...